Review



igfbp-6 protein  (PeproTech)


Bioz Verified Symbol PeproTech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    PeproTech igfbp-6 protein
    <t>IGFBP-6</t> shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.
    Igfbp 6 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/igfbp+6+protein/pmc09322660-56-27-13
    Average 90 stars, based on 1 article reviews
    igfbp-6 protein - by Bioz Stars, 2026-09
    90/100 stars

    Images

    1) Product Images from "Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells"

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells

    Journal: Frontiers in Molecular Biosciences

    doi: 10.3389/fmolb.2022.905468

    IGFBP-6 shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.
    Figure Legend Snippet: IGFBP-6 shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.

    Techniques Used: Expressing, Quantitative RT-PCR, Two Tailed Test, Western Blot

    IGFBP-6 is reduced by Dimethyl fumarate. (A) Cells were treated with 0.1% DMSO, 1 μg/ml LPS ± 50 µM DMF or (B) PBS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) IGFBP-6 secretion after stimulation with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 24 h. Data represent the mean ± SEM ( n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control (Wt or F508del) for each cell line.
    Figure Legend Snippet: IGFBP-6 is reduced by Dimethyl fumarate. (A) Cells were treated with 0.1% DMSO, 1 μg/ml LPS ± 50 µM DMF or (B) PBS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) IGFBP-6 secretion after stimulation with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 24 h. Data represent the mean ± SEM ( n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control (Wt or F508del) for each cell line.

    Techniques Used: Quantitative RT-PCR

    Anti-IGFBP-6 antibodies increased pro-inflammatory cytokines expression. (A) F508del-CFTR CFBE cells were treated with PBS or 0.2–200 ng/ml IGFBP-6 for 4 h. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test. (B) Cells were treated with 1 μg/ml LPS ± an antibody directed against IGFBP-6 (1 μg/ml) for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNF-α mRNAs normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test.
    Figure Legend Snippet: Anti-IGFBP-6 antibodies increased pro-inflammatory cytokines expression. (A) F508del-CFTR CFBE cells were treated with PBS or 0.2–200 ng/ml IGFBP-6 for 4 h. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test. (B) Cells were treated with 1 μg/ml LPS ± an antibody directed against IGFBP-6 (1 μg/ml) for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNF-α mRNAs normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test.

    Techniques Used: Expressing, Quantitative RT-PCR, Two Tailed Test

    IGFBP-6 shows higher expression in F508del / F508del nasal epithelial cells from three CF donors and reduces pro-inflammatory cytokines expression. (A) Total RNA was extracted from 2 patients homozygous for F508del mutation and 2 non-CF donors. qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 4). Statistical significance tested using paired two-tailed t -test (B) Cells were treated with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) Cells were treated with 200 ng/ml IGFBP-6 for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNFα mRNAs normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control for (Wt or F508del) each cell line.
    Figure Legend Snippet: IGFBP-6 shows higher expression in F508del / F508del nasal epithelial cells from three CF donors and reduces pro-inflammatory cytokines expression. (A) Total RNA was extracted from 2 patients homozygous for F508del mutation and 2 non-CF donors. qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 4). Statistical significance tested using paired two-tailed t -test (B) Cells were treated with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) Cells were treated with 200 ng/ml IGFBP-6 for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNFα mRNAs normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control for (Wt or F508del) each cell line.

    Techniques Used: Expressing, Mutagenesis, Quantitative RT-PCR, Two Tailed Test

    Related Articles

    Expressing:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Quantitative RT-PCR:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Two Tailed Test:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Western Blot:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Mutagenesis:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Purification:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).

    Positive Control:

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells
    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 μM VX-661 + 3 μM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Article Title: Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.
    Article Snippet: Purified IGFBP-6 (Peprotech, London, UK) was used a positive control (0.2 μg).



    Similar Products

    93
    MedChemExpress human igfbp6 protein
    Human Igfbp6 Protein, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/IGFBP-6%2C+Human/10__1161_slash_jaha__124__042132-147-0-7
    Average 93 stars, based on 1 article reviews
    human igfbp6 protein - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    R&D Systems recombinant human igfbp6
    Recombinant Human Igfbp6, supplied by R&D Systems, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/Recombinant+Human+IGFBP-6+Protein%2C+CF/bio_rxiv__2025__06__12__657772-340-4-8
    Average 93 stars, based on 1 article reviews
    recombinant human igfbp6 - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    93
    Boster Bio insulin like growth factor
    Insulin Like Growth Factor, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/Mouse+IGFBP-6+Recombinant+Protein/pm39701272-72-2-20
    Average 93 stars, based on 1 article reviews
    insulin like growth factor - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    96
    R&D Systems recombinant murine ctgf r d systems 9190 cc recombinant murine igfbp 1 r d systems 1588 b1
    Recombinant Murine Ctgf R D Systems 9190 Cc Recombinant Murine Igfbp 1 R D Systems 1588 B1, supplied by R&D Systems, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/Recombinant+Mouse+IL-6+Protein/pm38309273-202-34-37
    Average 96 stars, based on 1 article reviews
    recombinant murine ctgf r d systems 9190 cc recombinant murine igfbp 1 r d systems 1588 b1 - by Bioz Stars, 2026-09
    96/100 stars
      Buy from Supplier

    99
    Danaher Inc recombinant human igfbp 3 protein
    Recombinant Human Igfbp 3 Protein, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/Recombinant+human+IL-6+protein/pmc09698049-126-0-7
    Average 99 stars, based on 1 article reviews
    recombinant human igfbp 3 protein - by Bioz Stars, 2026-09
    99/100 stars
      Buy from Supplier

    90
    PeproTech igfbp-6 protein
    <t>IGFBP-6</t> shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.
    Igfbp 6 Protein, supplied by PeproTech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/igfbp+6+protein/pmc09322660-56-27-13
    Average 90 stars, based on 1 article reviews
    igfbp-6 protein - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Bioscientifica Ltd insulin-like growth factor-binding proteins (igfbps) 1–6
    <t>IGFBP-6</t> shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.
    Insulin Like Growth Factor Binding Proteins (Igfbps) 1–6, supplied by Bioscientifica Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/insulin+like+growth+factor+binding+proteins++igfbps++1+6/pm29255001-17-18-13
    Average 90 stars, based on 1 article reviews
    insulin-like growth factor-binding proteins (igfbps) 1–6 - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    90
    Millipore human igf binding protein (igfbp-6) magnetic bead panel
    <t>IGFBP-6</t> shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.
    Human Igf Binding Protein (Igfbp 6) Magnetic Bead Panel, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/igfbp-6+protein/igf+1+growth+factor/pmc05617388-211-13-22
    Average 90 stars, based on 1 article reviews
    human igf binding protein (igfbp-6) magnetic bead panel - by Bioz Stars, 2026-09
    90/100 stars
      Buy from Supplier

    Image Search Results


    IGFBP-6 shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells

    doi: 10.3389/fmolb.2022.905468

    Figure Lengend Snippet: IGFBP-6 shows higher expression in F508del-CFTR CFBE cells and is further increased after LPS treatment. (A) Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test. (B) Immunoblots of basal expression of IGFBP-6 in Wt and F508del-CFTR CFBE cells. (C) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin ( n = 3). Statistical significance tested using paired two-tailed t -test. (D,E) Cells were treated with 1 μg/ml LPS for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP-6 mRNA s normalized first to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test (F) Immunoblots of IGFBP-6 following treatment with 1 μg/ml LPS for 24 h. (G) Data represent the mean ± SEM of the ratio IGFBP-6/Calnexin normalized to Calnexin control ( n = 3–4). * p < 0.05; ** p < 0.01; **** p < 0.0001.

    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 µM VX-661 + 3 µM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Techniques: Expressing, Quantitative RT-PCR, Two Tailed Test, Western Blot

    IGFBP-6 is reduced by Dimethyl fumarate. (A) Cells were treated with 0.1% DMSO, 1 μg/ml LPS ± 50 µM DMF or (B) PBS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) IGFBP-6 secretion after stimulation with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 24 h. Data represent the mean ± SEM ( n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control (Wt or F508del) for each cell line.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells

    doi: 10.3389/fmolb.2022.905468

    Figure Lengend Snippet: IGFBP-6 is reduced by Dimethyl fumarate. (A) Cells were treated with 0.1% DMSO, 1 μg/ml LPS ± 50 µM DMF or (B) PBS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) IGFBP-6 secretion after stimulation with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 24 h. Data represent the mean ± SEM ( n = 3). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control (Wt or F508del) for each cell line.

    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 µM VX-661 + 3 µM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Techniques: Quantitative RT-PCR

    Anti-IGFBP-6 antibodies increased pro-inflammatory cytokines expression. (A) F508del-CFTR CFBE cells were treated with PBS or 0.2–200 ng/ml IGFBP-6 for 4 h. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test. (B) Cells were treated with 1 μg/ml LPS ± an antibody directed against IGFBP-6 (1 μg/ml) for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNF-α mRNAs normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells

    doi: 10.3389/fmolb.2022.905468

    Figure Lengend Snippet: Anti-IGFBP-6 antibodies increased pro-inflammatory cytokines expression. (A) F508del-CFTR CFBE cells were treated with PBS or 0.2–200 ng/ml IGFBP-6 for 4 h. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test. (B) Cells were treated with 1 μg/ml LPS ± an antibody directed against IGFBP-6 (1 μg/ml) for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNF-α mRNAs normalized to GADPH as housekeeping gene and then to control untreated cells. Data represent the mean ± SEM ( n = 3). Statistical significance tested using paired two-tailed t -test.

    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 µM VX-661 + 3 µM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Techniques: Expressing, Quantitative RT-PCR, Two Tailed Test

    IGFBP-6 shows higher expression in F508del / F508del nasal epithelial cells from three CF donors and reduces pro-inflammatory cytokines expression. (A) Total RNA was extracted from 2 patients homozygous for F508del mutation and 2 non-CF donors. qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 4). Statistical significance tested using paired two-tailed t -test (B) Cells were treated with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) Cells were treated with 200 ng/ml IGFBP-6 for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNFα mRNAs normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control for (Wt or F508del) each cell line.

    Journal: Frontiers in Molecular Biosciences

    Article Title: Insulin-Like Growth Factor Binding Protein (IGFBP-6) as a Novel Regulator of Inflammatory Response in Cystic Fibrosis Airway Cells

    doi: 10.3389/fmolb.2022.905468

    Figure Lengend Snippet: IGFBP-6 shows higher expression in F508del / F508del nasal epithelial cells from three CF donors and reduces pro-inflammatory cytokines expression. (A) Total RNA was extracted from 2 patients homozygous for F508del mutation and 2 non-CF donors. qRT-PCR was performed in order to quantify IGFBP-6 mRNA normalized to GADPH as housekeeping gene. Data represent the mean ± SEM ( n = 4). Statistical significance tested using paired two-tailed t -test (B) Cells were treated with 0.1% DMSO, 1 μg/ml LPS, 30 ng/ml IL-1β + 30 ng/ml TNFα ± 50 µM DMF for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IGFBP mRNA normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). (C) Cells were treated with 200 ng/ml IGFBP-6 for 4 h. Total RNA was extracted and qRT-PCR was performed in order to quantify IL-1β, IL-6 and TNFα mRNAs normalized to control untreated cells. Data represent the mean ± SEM ( n = 4). * p < 0.05; ** p < 0.01; *** p < 0.001; **** p < 0.0001. Statistical significance tested using two-way ANOVA with Tukey’s multiple comparisons test to the control for (Wt or F508del) each cell line.

    Article Snippet: Cells were treated for 24 h with 0.1% DMSO or 200 ng/ml IGFBP-6 (PeproTech) or 3 µM VX-661 + 3 µM VX-445 (Selleck Chemicals) +/− 200 ng/ml IGFBP-6.

    Techniques: Expressing, Mutagenesis, Quantitative RT-PCR, Two Tailed Test